DNA vaccines: Successes and limitations in cancer and infectious disease
- 26 January 2006
- journal article
- review article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 98 (2) , 235-242
- https://doi.org/10.1002/jcb.20775
Abstract
Vaccination with plasmid DNA is an active area of investigation that is being applied to diseases including cancer and microbial pathogens associated with infectious diseases. Since its discovery, great progress has been made with the administration of DNA vaccines to initiate specific and effective immune responses against targeted illnesses. However, many obstacles still face its use in prophylactic and therapeutic vaccination scenarios. The nature of these difficulties alongside the successes and future of plasmid DNA will be discussed. J. Cell. Biochem. 98: 235–242, 2006.Keywords
This publication has 60 references indexed in Scilit:
- Immunoselective Pressure and Human Leukocyte Antigen Class I Antigen Machinery Defects in Microsatellite Unstable Colorectal CancersCancer Research, 2005
- Haplotype Loss of HLA Class I Antigen as an Escape Mechanism from Immune Attack in Lung CancerCancer Research, 2005
- High numbers of tumour‐infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testisThe Journal of Pathology, 2005
- Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapyBreast Cancer Research and Treatment, 2005
- Evidence against a Role for SV40 in Human MesotheliomaCancer Research, 2005
- Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue virusesNature Medicine, 2004
- Effect of Dose on Immune Response in Patients Vaccinated With an HER-2/neu Intracellular Domain Protein—Based VaccineJournal of Clinical Oncology, 2004
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Induction of Potent Th1‐Type Immune Responses from a Novel DNA Vaccine for West Nile Virus New York Isolate (WNV‐NY1999)The Journal of Infectious Diseases, 2001
- Presence of simian virus 40 sequences in malignant pleural, peritoneal and noninvasive mesotheliomasInternational Journal of Cancer, 2000